Also this year on July 28th UMdL agrees with the World Hepatitis Day “ELIMINATE HEPATITIS” promoted by World Hepatitis Alliance, NOhep, and supported by World Health Organization (WHO) and by Centers for Disease Control and Prevention (CDC).
UMdL actively support the Campaign (here all Supporter Organizations).
Around the World there are a lot of events planned for this happening (it is possible to find them here).
After 1 year NOhep online activities have reached a lot of people (patients, health professionals, civil society, common people, …); there is also an ongoing development of the Campaign about Viral Hepatitis Elimination (take action for support Campaign).
The NOhep main motto is “Make the Elimination of Viral Hepatitis Our Next Greatest Achievement”.
Below the NOhep video “Make the elimination of viral hepatitis our next greatest achievemement“, Italian subs are provided by UMdL.
Shown below 2 pictures about NOhep Campaign with words by Nelson Mandela (and by Mahatma Gandhi.
Some pictures about viral hepatitis B and C :
- an animated gif about global hepatitis B and C (from WHO);
- a picture from the Campaign ELIMINATE HEPATITIS 2017;
- Data of DALYs (Disability-adjusted life years) 2015 about viral hepatitis B, cirrhosis, liver cancer in Italy (info from www.healthdata.org);
- Data of DALYs (Disability-adjusted life years) 2015 about viral hepatitis B, cirrhosis, liver cancer in Italy (info from www.healthdata.org);.
The World Health Assembly endorsed the Global Health Sector Strategy (GHSS) on viral hepatitis 2016–2021. The GHSS calls for the elimination of viral hepatitis as a public health threat by 2030 (reducing new infections by 90% and mortality by 65%). Here the WHO Global Hepatitis Report 2017 .
On July 28th 1925 in New York was born Dr. Baruch Samuel Blumberg. He discovered the hepatitis B virus in 1967 and he and his colleagues developed the first hepatitis B vaccine in 1969 and for these achievements won the Nobel Prize in 1976. Starting from his seminal article researchers have made a lot of progress towards prevention and treatment of all viral hepatitis.
There are five different hepatitis virus (A, B, C, D and E) and there are different ways of transmission (B,C and D are mainly spread by blood-to-blood contact and sometimes by other body fluids; A and E are mainly transmitted by poor sanitation and contaminated water or food).
All hepatitis viruses can cause inflammation of the liver, and chronic hepatitis B and C can lead to cirrhosis and liver cancer. Around 240 million people live with chronic hepatitis B and around 130–150 million people globally have chronic hepatitis C infection.[2, 3]
Every day about 4,000 people die from viral Hepatitis B and C worldwide (1.45 million people every year). Anyone can receive the hepatitis B vaccine above all if people have not previously received a sufficient vaccination. People at risk of hepatitis B infection include who inject drugs, healthcare professionals, prison staff and sex workers, among others. Currently are available new Hepatitis B guidelines by WHO. 
Every year at least 16 billion injections are administered worldwide (about 90% of these ones are given in curative care). Information provided by WHO show that every year around 8 billion injections for treatments can be replaced delivering medication by mouth. Unsafe injections are responsible for as many as 33,800 HIV infections, 1.7 million hepatitis B infections and 315,000 hepatitis C infections annually. Both patients and healthcare professionals are at risk through “needle stick” injuries. According to WHO and other international associations (Safe Injection Global Network (SIGN), UNICEF and GAVI Alliance) cornerstone for this battle is education about the importance of sterile equipment, safe procedures, elimination of unnecessary injections and better design of equipment. Currently there are a lot of new smart syringes in commerce . These devices have been engineered with an auto-disable features or re-use prevention features. More information are also available on the new WHO guidelines on this topic. 
Lucio Fellone (email@example.com / firstname.lastname@example.org) / last updated 07/28/2017
Blumberg BS, Alter HJ, Visnich S. A ‘‘new’’ antigen in leukemia sera. JAMA 1965;191:541-546 [Pubmed].
World Health Organization – Media Centre – Hepatitis B Fact Sheet N°204: http://www.who.int/mediacentre/factsheets/fs204/en/ [Last accessed July 2015].
World Health Organization – Media Centre – Hepatitis C Fact Sheet N°164: http://www.who.int/mediacentre/factsheets/fs164_apr2014/en/ [Last accessed July 2015].
World Health Organization – Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Published on March 2015. Pp.166.ISBN:978 92 4 154905 9. http://www.who.int/mediacentre/news/releases/2015/hepatitis-b-guideline/en/ .
World Health Organization – Injection safety – Injection safety policy and global campaign: http://www.who.int/injection_safety/global-campaign/en/ [Last accessed July 2015].
World Health Organization – WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health-care settings. WHO/HIS/SDS/2015.5. http://www.who.int/injection_safety/global-campaign/injection-safety_guidline.pdf?ua=1 .